Template:Meropenem: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{{Meropenem}}
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Meropenem|{{fontcolor|#6C7B8B|Meropenem}}]]'''''
{{CMG}}
|-
==Overview==
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | MERREM<sup>®</sup> FDA Package Insert
Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca with the brand names Merrem® and Meronem®. Other brand names include Mepem® (Taiwan) and Meropen® (Japan, Korea). It gained FDA approval in July 1996. It penetrates well into many tissues and body fluids including the cerebrospinal fluid, bile, heart valves, lung, and peritoneal fluid.[1]
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem description|Description]]
==FDA Package Insert==
|-
'''[[Meropenem description|Description]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem clinical pharmacology|Clinical Pharmacology]]
'''| [[Meropenem clinical pharmacology|Clinical Pharmacology]]'''
|-
'''| [[Meropenem microbiology|Microbiology]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem microbiology|Microbiology]]
'''| [[Meropenem indications and usage|Indications and Usage]]'''
|-
'''| [[Meropenem contraindications|Contraindications]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem indications and usage|Indications and Usage]]
'''| [[Meropenem warnings|Warnings]]'''
|-
'''| [[Meropenem precautions|Precautions]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem contraindications|Contraindications]]
'''| [[Meropenem adverse reactions|Adverse Reactions]]'''
|-
'''| [[Meropenem overdosage|Overdosage]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem warnings|Warnings]]
'''| [[Meropenem clinical studies|Clinical Studies]]'''
|-
'''| [[Meropenem dosage and administration|Dosage and Administration]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem precautions|Precautions]]
'''| [[Meropenem compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]'''
|-
'''| [[Meropenem directions for use|Directions For Use]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem adverse reactions|Adverse Reactions]]
'''| [[Meropenem how supplied|How Supplied]]'''
|-
'''| [[Meropenem other size packages available|Other Size Packages Available]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem overdosage|Overdosage]]
'''| [[Meropenem labels and packages|Labels and Packages]]'''
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem clinical studies|Clinical Studies]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem how supplied|How Supplied]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Meropenem labels and packages|Labels and Packages]]
|-
|}

Latest revision as of 02:09, 26 December 2013